Waisman Clinical Biomanufacturing Facility is a prominent supplier to the pharmaceutical industry, specialising in a range of services essential for the development and manufacturing of biopharmaceutical products. The facility offers an array of solutions designed to support the entire lifecycle of biologic drugs, from process development through to clinical trials and manufacturing, ensuring high-quality products for the market.

Services include:

– Aseptic Fill/Finish
– Biologics
– Process Development
– Bioprocessing
– Clinical Trials
– Contract Manufacturing (CMO)
– Fermentation
– Manufacturing
– Aseptic Fill-Finish
– Clinical Trial Materials
– Dose Form
– Sterile
– Injectables
– Microbial-based Therapeutic Proteins
– Parenterals
– Large Volume
– Small Volume
– Proteins
– Vaccines
– Vials

Waisman Clinical Biomanufacturing Facility remains committed to advancing biomanufacturing capabilities and ensuring the highest standards of service for its clients. For more information, please visit GMPbio.org.